Diuresis and Diuretic Pharmacology
Diuresis and Diuretic Pharmacology
David Ray Velez, MD
Table of Contents
Classes:
Loop Diuretics
Thiazide Diuretics
Potassium-Sparing Diuretics
Carbonic Anhydrase Inhibitors (CAI)
Osmotic Diuretics
General Electrolyte Changes:
K+ | Ca2+ | Mg2+ | Na+ | H+ | ||
Loops | Furosemide | Down | Down | Down | Up | Down |
Thiazides | Hydrochlorothiazide | Down | Up | Down | Down | Down |
K-Sparing | Spironolactone | Up | – | Up | Down | Up |
CAI | Acetazolamide | Down | Down | Down | Down | Up |
Loop Diuretics
Strongest Diuretic Effect
Agents
- Furosemide (Lasix) – Most Common
- Torsemide
- Bumetanide (Bumex)
Mechanism
- Acts in the Thick Ascending Limb of the Loop of Henle
- Inhibits the Na-K-2Cl Carrier in the Luminal Membrane
- Prevents NaCl Reabsorption
- Decreased Intracellular Tonicity Prevents Free Water Reabsorption
- Additional Effects:
- Directly Inhibits Potassium Reabsorption – Potassium Loss
- Inhibits the Electrical Gradient that Drives Calcium Reabsorption – Calcium Loss
- Increased Sodium Delivery to Distal Nephron Increases Na-H Exchange – Hydrogen Loss (Alkalosis)
- Water Reabsorption Prevented in the Loop of Henle While Sodium is Reabsorbed in More Distal Nephron, Inhibiting Renal Ability to Concentrate Urine – Increase in Sodium Levels
Pharmacokinetics
- Oral (PO):
- Onset of Action: 1 Hour
- Peak Effect: 1-2 Hours
- Duration: 6-8 Hours
- Intravenous (IV):
- Onset of Action: 5 Minutes
- Peak Effect: 30 Minutes
- Duration: 2 Hours
- Excreted in Urine (Minimal Hepatic Metabolism)
Furosemide (Lasix) Dosing
- Generally Start with Low Dose (10-20 mg) in the ICU and Increase as Tolerated if Necessary
- May Require BID Dosing
- 10 mg IV is Approximately Equivalent to 20 mg PO
Side Effects
- Hypokalemia
- Hypocalcemia
- Hypernatremia
- Metabolic Alkalosis
- Ototoxicity
Thiazide Diuretics
Relatively Weak Diuretic Effect – DCT Normally Reabsorbs Only 5-10% of the Filtered Sodium Load
Agents
- Hydrochlorothiazide (HCTZ) – Most Common
- Only Available PO
- Chlorothiazide (Diuril)
- Can Be Given PO or IV
- Chlorthalidone
- Indapamide
Mechanism
- Acts in the Distal Convoluted Tubule (DCT)
- Inhibits the Na-Cl Transporter in the Luminal Membrane
- Prevents NaCl Reabsorption
- Decreased Intracellular Tonicity Prevents Free Water Reabsorption
- Additional Effects:
- Increased Sodium Delivery to Distal Nephron Increases Na-K Exchange – Causes Potassium Loss
- Increased Sodium Delivery to Distal Nephron Increases Calcium Reabsorption Through a Na/Ca Transporter
- Increased Sodium Delivery to Distal Nephron Increases Na-H Exchange – Causes Hydrogen Loss (Alkalosis)
Pharmacokinetics
- PO Hydrochlorothiazide:
- Onset of Action: 2 Hour
- Peak Effect: 4 Hours
- Duration: 24 Hours
- IV Chlorothiazide:
- Onset of Action: 15 Minutes
- Peak Effect: 30 Minutes
- Duration: 2 Hours
- Excreted in Urine (Not Metabolized)
Dosing
- PO Hydrochlorothiazide: 25-100 mg Daily or Divided Doses
- IV Chlorothiazide: 250 mg – 1 g Once-Twice Daily
Side Effects
- Hypokalemia – More Common than with Loop Diuretics
- Hypercalcemia – Increased Reabsorption
- Metabolic Alkalosis
- Gout
- Acute Angle Glaucoma
- Skin Sensitivity
Potassium-Sparing Diuretics
Also Known As: Mineralocorticoid/Aldosterone Receptor Antagonist (MRA)
Relatively Weak Diuretic Effect
Agents
- Spironolactone (Aldactone) – Most Common
- Amiloride
- Eplerenone
- Triamterene
Mechanism
- Acts in the Distal Convoluted Tubule (DCT)
- Inhibits Mineralocorticoid/Aldosterone Receptors
- Aldosterone is a Component of the Renin-Angiotensin-Aldosterone System (RAAS)
- Prevents Sodium Reabsorption and Potassium Excretion
- Decreased Intracellular Tonicity Prevents Free Water Reabsorption
- Additional Effects:
- Prevents Hydrogen Excretion (Acidosis)
- Prevents Magnesium Excretion
Pharmacokinetics
- Slow Onset of Action
- May Take 48 Hours to See Peak Effect
- Hepatic Metabolism, Excreted in Urine (Primary) and Bile (Secondary)
Spironolactone (Aldactone) Dosing
- 5-50 mg PO Daily or Divided Doses
Side Effects
- Hyperkalemia
- Metabolic Acidosis
- Antiandrogen Effects (Gynecomastia, Dysmenorrhea)
Carbonic Anhydrase Inhibitors (CAI)
Relatively Weak Diuretic Effect
Agents
- Acetazolamide (Diamox)
Mechanism
- Acts in the Proximal Convoluted Tubule (PCT)
- Carbonic Anhydrase Inhibitor (CAI)
- Prevents Breakdown of Carbonic Acid (H2CO3)
- Prevents Acidification of the Urine and Reabsorption of Bicarbonate – Can Be Used in the Treatment of Metabolic Alkalosis
- Inhibits Na-H Exchange Preventing Sodium Reabsorption
- Decreased Intracellular Tonicity Prevents Free Water Reabsorption
Pharmacokinetics
- Oral (PO):
- Onset of Action: 1 Hour (Immediate Release), 2 Hours (Extended Release)
- Peak Effect: 2-4 Hours (Immediate Release), 8-18 Hours (Extended Release)
- Duration: 8-12 Hours (Immediate Release), 18-24 Hours (Extended Release)
- Intravenous (IV):
- Onset of Action: 2-10 Minutes
- Peak Effect: 15 Minutes
- Duration: 4-5 Hours
- Renal Excretion
Acetazolamide (Diamox) Dosing
- 250-500 mg Once Daily (PO or IV)
Side Effects
- Hypokalemia
- Hypocalcemia
- Metabolic Acidosis
- Aplastic Anemia
- Paresthesia
- Growth Retardation
Osmotic Diuretics
Used More Commonly in the ICU for TBI and Not Specifically for the Diuretic Effects
Agents
- Mannitol
- Isosorbide
Mechanism
- Acts Primarily in the Proximal Convoluted Tubule (PCT) and Loop of Henle Where Water is Freely Permeable
- Non-Reabsorbable Solute Prevents Water Reabsorption
Mannitol Use in Intracranial Hypertension
- Used to Decrease ICP in TBI
- Rheologic Effect:
- Changes the Shape of RBC’s to Decrease Viscosity, Improve Cerebral Blood Flow, and Decrease ICP
- The Primary Mechanism of Effect on ICP Occurs within Minutes
- Osmotic Effect:
- Causes Osmotic Removal of Fluid from the Brain
- Secondary Mechanism and Takes Longer (15-30 Minutes)
- Due to Diuretic Effect, it Should Be Avoided in Hypotensive/Hypovolemic
Pharmacokinetics
- Onset of Action: 5-10 Minutes
- Duration: 3-6 Hours
- Renal Excretion
Mannitol Dosing
- 25-2.0 g/kg IV
Side Effects
- Hypovolemia
- Hyponatremia
- Hypokalemia